AVDL
Avadel Pharmaceuticals
AVDL
AVDL
Delisted
AVDL was delisted on the 11th of February, 2026.
94 hedge funds and large institutions have $435M invested in Avadel Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 30 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
31% more capital invested
Capital invested by funds: $332M → $435M (+$103M)
41% less call options, than puts
Call options by funds: $910K | Put options by funds: $1.53M
Holders
94
Holding in Top 10
4
Calls
$910K
Puts
$1.53M
Top Buyers
| 1 | +$9.51M | |
| 2 | +$8.52M | |
| 3 | +$6.58M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.32M |
| 5 |
MACM
March Altus Capital Management
Greenwich,
Connecticut
|
+$5.64M |
Top Sellers
| 1 | -$18.3M | |
| 2 | -$12.7M | |
| 3 | -$5.72M | |
| 4 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$3.62M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.3M |